Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study - Bilici, Ahmet; Uysal, Mukremin; Menekse, Serkan; Akin, Semih; Yildiz, Fatih; Turan, Merve; Sezgin Goksu, Sema; Beypinar, Ismail; Sakalar, Teoman; Degirmenci, Mustafa; Erdem, Dilek; Basaran, Gul; et al. (TAYLOR \& FRANCIS INC, 2022)
Keywords: Everolimus; exemestane; metastatic breast cancer; hormone receptor\\-positive; HER \\- negative; efficacy